C. Suárez

Impact of the incorporation of a nurse in an inflammatory bowel disease unit

M. Calvo, Y. González-Lama, M. Vera, 2016 .

Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.

M. Calvo, Y. González-Lama, M. Vera, 2016, Journal of Crohn's & colitis.

Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

J. Gisbert, U. Aguirre, M. Piqueras, 2020, United European gastroenterology journal.

Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas

P. Chiodini, D. Nolder, C. Suárez, 2022, Research and reports in tropical medicine.

Musculoskeletal Infection in Orthopaedic Trauma: Assessment of the 2018 International Consensus Meeting on Musculoskeletal Infection.

Stephen M. Quinnan, M. Swiontkowski, R. O’Toole, 2019, The Journal of bone and joint surgery. American volume.

I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.

Jordi Espadaler Mazo, J. Serra, V. Lorenzo-Zúñiga, 2014, World journal of gastroenterology.

Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab.

Marta Hernández, M. Calvo, A. Ramos, 2015, Gastroenterologia y hepatologia.

Impact of endoscopic monitoring in postoperative Crohn's disease patients already receiving pharmacological prevention of recurrence.

M. Calvo, Y. González-Lama, L. Abreu, 2015, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Mucosal healing in Crohn's disease: relevance and controversies in real life clinical practice.

M. Calvo, Y. González-Lama, L. Abreu, 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

A NEW COMBINATION OF PROBIOTICS , IMPROVES IRRITABLE BOWEL SYNDROME-RELATED QUALITY OF LIFE . A PILOT , DOSE-FINDING , MULTICENTER , DOUBLE BLIND , PLACEBO-CONTROLLED CLINICAL TRIAL

Jordi Espadaler Mazo, J. Serra, L. Abreu, 2014 .